Skip to main content
logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.53661
-0.0133 (-2.42%)
Sep 22, 2026, 11:12 AM EDT - Market open

RedHill Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.43-8.2723.92-71.67-97.74
Depreciation & Amortization
0.410.621.998.1518.15
Loss (Gain) on Equity Investments
0.03----
Stock-Based Compensation
0.460.671.655.6810.21
Other Operating Activities
-8.15-4.44-47.7520.655.49
Change in Accounts Receivable
2.260.0531.93-2.85-3.02
Change in Inventory
-0.380.742.393.8-8.29
Change in Accounts Payable
-0.44-2.11-0.95-7.430.11
Change in Other Net Operating Assets
-3.423.37-48.9814.4910.04
Operating Cash Flow
-7.19-8.94-16.82-29.19-65.05
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0.01-0.2-0.12
Investment in Securities
1.7-0.028.5-8.03
Other Investing Activities
-1.7----
Investing Cash Flow
-0.01-0.0108.3-8.14

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-0.45-0.64-1.18-1.48-1.68
Lease Payments
-0.45-0.64-1.18-1.48-1.68
Net Debt Issued (Repaid)
-0.45-0.64-1.18-1.48-1.68
Issuance of Common Stock
7.768.2613.9623.8182.54
Other Financing Activities
-0.320.84-10.88-7.4
Financing Cash Flow
7.327.9413.6211.4573.46

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-00.01-0.02-0.08-0.1
Net Cash Flow
0.12-0.99-3.22-9.510.18

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.2-8.94-16.83-29.38-65.16
Free Cash Flow Growth
-----
Free Cash Flow Margin
-2516.08%---47.55%-75.98%
Free Cash Flow Per Share
-2.28-7.26-64.96-476.76-1400.52
Levered Free Cash Flow
-2.183.08-8.98-52.39-34.94
Unlevered Free Cash Flow
-2.163.11-8.94-26.56-24.58
Free Cash Flow After Leases
-7.64-9.58-18.01-30.86-66.85

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.020.060.378.1811.28
Change in Working Capital
-1.972.05-15.628.01-1.15
SEC Filings: 10-K · 10-Q